Pleasanton, CA, United States of America

Isidore Rosenblum

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Ping Identity Corporation. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isidore Rosenblum. Retrieved from https://idiyas.com/inventor/isidore-rosenblum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Isidore Rosenblum - Pioneering Innovations

Introduction: Isidore Rosenblum, a distinguished inventor based in Pleasanton, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Isidore Rosenblum holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Isidore Rosenblum has a proven track record of developing cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Isidore Rosenblum has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Isidore Rosenblum's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…